These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 23767426)
1. Increased urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG)/creatinine level is associated with the progression of normal-tension glaucoma. Yuki K; Tsubota K Curr Eye Res; 2013 Sep; 38(9):983-8. PubMed ID: 23767426 [TBL] [Abstract][Full Text] [Related]
2. Low diastolic blood pressure is associated with the progression of normal-tension glaucoma. Okumura Y; Yuki K; Tsubota K Ophthalmologica; 2012; 228(1):36-41. PubMed ID: 22377835 [TBL] [Abstract][Full Text] [Related]
3. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker? Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500 [TBL] [Abstract][Full Text] [Related]
4. Visual field progression differences between normal-tension and exfoliative high-tension glaucoma. Ahrlich KG; De Moraes CG; Teng CC; Prata TS; Tello C; Ritch R; Liebmann JM Invest Ophthalmol Vis Sci; 2010 Mar; 51(3):1458-63. PubMed ID: 20042657 [TBL] [Abstract][Full Text] [Related]
5. Intraocular pressure reduction with topical medications and progression of normal-tension glaucoma: a 12-year mean follow-up study. Kim M; Kim DM; Park KH; Kim TW; Jeoung JW; Kim SH Acta Ophthalmol; 2013 Jun; 91(4):e270-5. PubMed ID: 23406253 [TBL] [Abstract][Full Text] [Related]
6. Silent cerebral infarct and visual field progression in newly diagnosed normal-tension glaucoma: a cohort study. Leung DY; Tham CC; Li FC; Kwong YY; Chi SC; Lam DS Ophthalmology; 2009 Jul; 116(7):1250-6. PubMed ID: 19481813 [TBL] [Abstract][Full Text] [Related]
7. Urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in workers exposed to ethylbenzene. Chang FK; Mao IF; Chen ML; Cheng SF Ann Occup Hyg; 2011 Jun; 55(5):519-25. PubMed ID: 21430133 [TBL] [Abstract][Full Text] [Related]
8. The association between systemic oxidative stress and ocular blood flow in patients with normal-tension glaucoma. Himori N; Kunikata H; Shiga Y; Omodaka K; Maruyama K; Takahashi H; Nakazawa T Graefes Arch Clin Exp Ophthalmol; 2016 Feb; 254(2):333-41. PubMed ID: 26514963 [TBL] [Abstract][Full Text] [Related]
9. Optic disc torsion direction predicts the location of glaucomatous damage in normal-tension glaucoma patients with myopia. Park HY; Lee K; Park CK Ophthalmology; 2012 Sep; 119(9):1844-51. PubMed ID: 22595297 [TBL] [Abstract][Full Text] [Related]
10. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Nouri-Mahdavi K; Hoffman D; Coleman AL; Liu G; Li G; Gaasterland D; Caprioli J; Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314 [TBL] [Abstract][Full Text] [Related]
11. Central visual field progression in normal-tension glaucoma patients with autonomic dysfunction. Park HY; Park SH; Park CK Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2557-63. PubMed ID: 24692126 [TBL] [Abstract][Full Text] [Related]
12. Comparison of visual field progression between relatively low and high intraocular pressure groups in normal tension glaucoma patients. Lee J; Kong M; Kim J; Kee C J Glaucoma; 2014; 23(8):553-60. PubMed ID: 23751927 [TBL] [Abstract][Full Text] [Related]
13. Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage. Prata TS; De Moraes CG; Teng CC; Tello C; Ritch R; Liebmann JM Ophthalmology; 2010 Jan; 117(1):24-9. PubMed ID: 19896197 [TBL] [Abstract][Full Text] [Related]
14. Correlation between intraocular pressure level and optic disc changes in high-tension glaucoma suspects. Tanito M; Itai N; Dong J; Ohira A; Chihara E Ophthalmology; 2003 May; 110(5):915-21. PubMed ID: 12750089 [TBL] [Abstract][Full Text] [Related]
15. Progression of visual field defects in eyes with different optic disc appearances in patients with normal tension glaucoma. Nakazawa T; Shimura M; Ryu M; Himori N; Nitta F; Omodaka K; Doi H; Yasui T; Fuse N; Nishida K J Glaucoma; 2012 Aug; 21(6):426-30. PubMed ID: 22314251 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of visual field progression in medically treated normal-tension glaucoma patients with unstable ocular perfusion pressure. Sung KR; Cho JW; Lee S; Yun SC; Choi J; Na JH; Lee Y; Kook MS Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):737-43. PubMed ID: 20861474 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for visual field progression in the low-pressure glaucoma treatment study. De Moraes CG; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T; Am J Ophthalmol; 2012 Oct; 154(4):702-11. PubMed ID: 22835512 [TBL] [Abstract][Full Text] [Related]
18. Frequency of asymmetric visual field defects in normal-tension and high-tension glaucoma. Poinoosawmy D; Fontana L; Wu JX; Bunce CV; Hitchings RA Ophthalmology; 1998 Jun; 105(6):988-91. PubMed ID: 9627646 [TBL] [Abstract][Full Text] [Related]
19. Contributing factors for progression of visual field loss in normal-tension glaucoma patients with medical treatment. Sakata R; Aihara M; Murata H; Mayama C; Tomidokoro A; Iwase A; Araie M J Glaucoma; 2013 Mar; 22(3):250-4. PubMed ID: 23059475 [TBL] [Abstract][Full Text] [Related]
20. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Caprioli J; Coleman AL Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]